By inhibiting the activation of tyrosine kinase and regulating the BARHL1–ESR1 axis to reduce β-amyloid processing, the progression of neurodegenerative diseases, such as AD, can be slowed down [35]. Here, BARHL1 is linked to neurodegenerative disease.